Mar 4, 2026 04:01PM
Aug 7, 2025 04:05PM
Jul 1, 2025 12:33PM
May 13, 2025 04:34PM
May 8, 2025 01:44PM
May 8, 2025 01:17PM
Apr 29, 2025 06:28AM Mizuho on Verastem (VSTM): 'we continue to favor it as a top small cap biotech idea'
Apr 10, 2025 03:34AM
Mar 25, 2025 04:35PM
Mar 24, 2025 07:26AM
Mar 20, 2025 04:01PM
Feb 20, 2025 04:05PM
Jan 24, 2025 08:22AM
Jan 23, 2025 07:31AM Verastem Oncology (VSTM) Outlines 2025 Strategic Priorities and Milestones for Novel Pipeline Targeting RAS/MAPK Pathway-Driven Cancers
Jan 23, 2025 07:30AM
Jan 13, 2025 12:50PM
Jan 13, 2025 07:31AM
Jan 13, 2025 07:30AM
Dec 30, 2024 11:27PM
Dec 30, 2024 04:32PM
Dec 30, 2024 04:30PM Verastem Oncology Announces FDA Acceptance and Priority Review of New Drug Application for Avutometinib in Combination with Defactinib for the Treatment of Recurrent KRAS Mutant Low-Grade Serous Ovari
Sep 25, 2018 05:39AM
Sep 24, 2018 01:30PM
Jul 13, 2018 07:50AM
Jun 15, 2018 09:08AM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All